BMC Pregnancy and Childbirth. Volume 19, Article number: 398 (2019)
“Changing diagnostic criteria for gestational diabetes in Sweden – a stepped wedge national cluster randomised controlled trial – the CDC4G study protocol”
The aim of the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) in Sweden is to evaluate the clinical and health economic impacts of changing diagnostic criteria for GDM in Sweden and to create a prospective cohort to compare the many long-term outcomes in mother and baby under the old and new diagnostic approaches.
Journal of Diabetes Research. Volume 2020, Article number: 7937403 (2020)
“Diagnosis of Gestational Diabetes Mellitus with Point-of-Care Methods for Glucose versus Hospital Laboratory Method Using Isotope Dilution Gas Chromatography-Mass Spectrometry as Reference”
In Sweden, both glucose analyzers in accredited laboratories and point-of-care glucose devices are used for gestational diabetes mellitus (GDM) diagnosis. The aim of this study was to compare the diagnostic performance of the HemoCue Glucose 201+ (HC201+) and RT (HC201RT) systems with that of the hospital central laboratory hexokinase method (CL) based on lyophilized citrate tubes, using the isotope dilution gas chromatography-mass spectrometry (ID GC-MS) as reference.